| 0 | 💬 0 |
Safety and Immunogenicity of a Fourth Dose of Omicron BA.1-Adapted BNT162b2 COVID-19 Vaccines in Adults 18-55 Years Old.
(academic.oup.com)
|
Clinical Infectious Diseases 2026-05-20 | #covid-19 #vaccination #immunity #immunogenicity #safety |